Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCGRT | P55899 | 1/20 | 0.60 |
| ▸ | MC4R | P32245 | 17/20 | 0.53 |
| ▸ | MC1R | Q01726 | 11/20 | 0.53 |
| ▸ | MC3R | P41968 | 10/20 | 0.53 |
| ▸ | MC5R | P33032 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20642817 | 1.00 | FCGRT (0.60) | FCGRTMC4RMC1RMC3RMC5R | |
| SCHEMBL20642819 | 0.94 | FCGRT (0.59) | FCGRTMC4RMC1RMC3RMC5R | |
| SCHEMBL20642697 | 0.94 | FCGRT (0.63) | FCGRTMC4RMC1RMC3RMC5R | |
| SCHEMBL20642595 | 0.93 | FCGRT (0.61) | FCGRTMC4RMC1RMC3RMC5R | |
| SCHEMBL20642771 | 0.92 | FCGRT (0.64) | FCGRTMC4RMC1RMC3RMC5R | |
| SCHEMBL19473991 | 0.91 | MC4R (0.66) | MC4RMC1RMC3RMC5R | |
| SCHEMBL19473791 | 0.91 | MC4R (0.66) | MC4RMC1RMC3RMC5R | |
| SCHEMBL19473989 | 0.91 | MC4R (0.66) | MC4RMC1RMC3RMC5R | |
| SCHEMBL10307917 | 0.91 | MC4R (0.66) | MC4RMC1RMC3RMC5R | |
| SCHEMBL13063946 | 0.91 | MC4R (0.66) | MC4RMC1RMC3RMC5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179804-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2019-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10179804-B2 | Melanocortin receptor-specific peptides | MC1R, MC3R, MC5R | FCGRT 216/4885MC4R 4/4885MC1R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.